SCHEMBL4346952

SCHEMBL4346952

CC(=O)Nc1cnc2[nH]cc(/C=C/C(N)=O)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP3K7 O43318 11/20 0.43
▸ TAB1 Q15750 11/20 0.43
▸ DYRK1A Q13627 2/20 0.41
▸ CLK1 P49759 1/20 0.41
▸ DYRK2 Q92630 1/20 0.41
▸ DYRK1B Q9Y463 1/20 0.41
▸ NTRK1 P04629 5/20 0.40
▸ KIT P10721 2/20 0.38
▸ CYP3A4 P08684 1/20 0.36
▸ MELK Q14680 3/20 0.36
▸ PRKD3 O94806 3/20 0.36
▸ MAP4K4 O95819 3/20 0.36
▸ EGFR P00533 3/20 0.36
▸ AXL P30530 3/20 0.36
▸ FLT4 P35916 3/20 0.36
▸ FLT3 P36888 3/20 0.36
▸ CLK2 P49760 3/20 0.36
▸ MAP4K2 Q12851 3/20 0.36
▸ CAMK2B Q13554 3/20 0.36
▸ CAMK2G Q13555 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4346955 1.00 MAP3K7 (0.43) MAP3K7TAB1DYRK1ACLK1DYRK2
SCHEMBL4350414 0.87 MAP3K7 (0.46) MAP3K7TAB1BTK
SCHEMBL4350420 0.87 MAP3K7 (0.46) MAP3K7TAB1BTK
SCHEMBL16932989 0.86 MAP3K7 (0.47) MAP3K7TAB1BTK
SCHEMBL16932988 0.86 MAP3K7 (0.47) MAP3K7TAB1BTK
SCHEMBL4346854 0.84 MAP3K7 (0.47) MAP3K7TAB1BTK
SCHEMBL4346848 0.84 MAP3K7 (0.47) MAP3K7TAB1BTK
SCHEMBL13821438 0.83 MAP3K7 (0.41) MAP3K7TAB1ABL1BTK
SCHEMBL4835466 0.83 DYRK1A (0.45) DYRK1ACLK1DYRK2DYRK1BNTRK1
SCHEMBL4343457 0.82 PRKD3 (0.53) MAP3K7TAB1DYRK1ACLK1NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2070928-A1 7-azaindol-3-ylacrylamides active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2009-06-17 — — EP claimed
EP-2070928-A1 7-azaindol-3-ylacrylamides active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2009-06-17 — — EP disclosed
EP-2070928-A1 7-azaindol-3-ylacrylamides active as kinase inhibitors NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2009-06-17 — — EP disclosed
Send feedback